@LAILIAO178 Thanks for your support. Rest assured, I only share facts from published news articles. Not empty talk without facts unlike some ppl in this forum...cough cough...
Here also got firecracker but wet one not that loud. The whole next week we will know if this Wu guy throw because insider bad news coming or something else brewing. Mind you all his shares thrown was fully absorbed and more buyers surfaced at 0.175 before closing.
@anthonytkh Please don't act smart. You can talk negative but once you personally attack someone, it becomes personal. That @jutawansenyap personally attacked me, so it is my right to defend myself.
Price well absorb because it is penny counter plus vaccine stock.
Insider can simply push the price and disposed higher.That is always the SOP for insider.Can refer to most of the counters in BSKL unless respective counter got new catalyst.Then only insider will buy again althought at higher price.
But now,insider was disposed almost all his stock.The price sideway,and remember what is it price before the vaccine news.
I experienced bought kanger at 32 cents which the day it suppossed to BREAK OUT.but it was a FALSE BREAK OUT few months ago.I managed to CL at 28.5cents at same day and luckily bought back again at 14/14.5 cents.Manage to cover first losses by selling second round at 20 cents.
3rd round bought again last month at about vaccine theme started price 18 cents.Unfortunately pick a wrong vaccine counter buy still manage to sell above 20 cents.
Kah kah kah.defensive.he is the one who attack comments who againts him. People buying stock by using fundamental analysis or technical analysis.But you are buying stock by reading faked news.Go and spend your money to gain knowledge rather than keep sharing news (actually indirectly promoting) Kekekeke
you two still havent settle the dispute? Prolong the dispute no benefit all at here. want to buy. buy lah. want to sell. sell lah. why insist you are always right? tomorrow up or down more important. correct?
yeah, stop come to the counter forum and talk shit. We all here have brain to make our own decision. Stop giving orders to people. People won't listening to you after all lol.
as i say u money u decide... i will always no call buy or sell, even will very strong not encourage cut loss... so if this kind of person... i dun think the ID he create suitable for him... so i will totally change their ID... i had kuat kuat taruk this aqua 1 time coz he ask ppl to cut loss...
i no mind you share any real fact... even if it a bad news... just dun share fake news, dun create fear... u can share your TP, so other believe or not... they will decide...
Of the two drugmakers' candidates, Sinovac's CoronaVac is likely China’s most "promising" vaccine, with the best chances of getting approved and distributed internationally because Sinovac has released more data, says Huang.
Brazil order 50mil- 2 doses vaccine from Sinovac delivery in Jan 2021 for mass vaccination. They also have trial in Indonesia. 2 highly populated nations.
@UlarSawa Sinopharm has already applied for regulatory approval from China authorities while Sinovac has not done so....Besides, Sinopharm conducted the world's first phase III clinical trials in UAE which has the advantage as the nation is home to more than 200 nationalities, allowing for robust research across multiple ethnicities, increasing the vaccine's feasibility for global application on the success of the trials. On November 17, Liu Jingzhen, chairman of Sinopharm, said that the vaccine candidates have been under Phase-3 clinical trials in 10 countries including the UAE, Bahrain, Egypt, Jordan, Peru, and Argentina, with nearly 60,000 people inoculated. The links to the above facts can be found below....
---------------------------- World's first phase-III COVID-19 vaccine clinical trial begins vaccination in UAE
Still, Sinopharm may have a built-in edge given its established distribution networks within China and the fact that it is testing its vaccine in a broader array of countries than other Chinese vaccine makers.
"[Sinopharm's] large scale rollout [via China's emergency use program] also means that there is already a large distribution system, which has already been stress-tested," says Nicholas Thomas, a vaccine expert and health governance professor at the City University of Hong Kong. "This is a major advantage in the future distribution." Sinopharm is also already distributing vaccines to the United Arab Emirates via that country's emergency use program, and is testing, or plans to conduct trials, in at least ten countries including Egypt, Jordan, and Argentina.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
NPRA1985
3,415 posts
Posted by NPRA1985 > 2020-12-06 18:53 | Report Abuse
Ya Lantak @Jutawansenyap kekeke